Each to your own. I thought the company may have been on a winner after the blind study results but after the last phase I'm not so sure so. I'm not saying it's a dud, just that it sucked a lot of the excitement out of this stock for me.
Has anyone seen any really good expert reports about the results?
Have the results sent shockwaves of hope through the herpes community?
Have media been pumping the results and talking about Admedus having a golden ticket?
Do the former directors believe?
Anyway, good luck to you all, it's just my decision based on my research and having dealt with too much 'hope' in the past with Admedus.
Each to your own. I thought the company may have been on a...
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.68 |
Change
0.680(4.53%) |
Mkt cap ! $331.4M | |||
| Open | High | Low | Value | Volume |
| $14.90 | $15.75 | $14.85 | $431.9K | 28.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200 | $15.21 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.95 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| AVR (ASX) Chart |